Inhibition of CCL19 Benefits Non‑alcoholic Fatty Liver Disease by Inhibiting TLR4/NF‑κB‑p65 Signaling
Molecular Medicine Reports - Greece
doi 10.3892/mmr.2018.9490
Full Text
Open PDFAbstract
Available in full text
Date
September 14, 2018
Authors
Publisher
Spandidos Publications